Skip to content

Fulcrum Therapeutics Inc

FULC

Latest QuantConomy context for FULC: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
11
Asset profile

Fulcrum Therapeutics Inc

QuantConomy has a structured record for FULC. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
FULC
Name
Fulcrum Therapeutics Inc
Coverage
3 market/data records
Sources
alpaca alphavantage fmp sec nasdaq
Latest signal rows

Recent signals for FULC

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
passive increase
slightly bullish
34
Jun 26, 02:15 AM EcoR1 Capital, LLC increased passive stake in FULC from 8.20% to 9.00% - (13G - passive investment) - 6,000,000 shares - [very weak slightly bullish signal]
passive increase
slightly bullish
34
Jun 26, 02:15 AM EcoR1 Capital, LLC increased passive stake in FULC from 8.20% to 9.00% - (13G - passive investment) - 6,000,000 shares - [very weak slightly bullish signal]
other event
neutral
40
Jun 25, 08:45 PM FULC filed 8-K: Shareholder Vote Results - [weak neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

OWNERSHIP signals are experimental: historical 13D/G coverage is still being backfilled, so results may be sparse or empty.

Market coverage

Market Exchange Source Asset record
FULC NASDAQ alpaca Fulcrum Therapeutics, Inc. Common Stock
FULC NASDAQ alphavantage Fulcrum Therapeutics Inc
FULC NASDAQ fmp Fulcrum Therapeutics, Inc.

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
11
Date Insider Role Type Shares Price Value Filing
Apr 23, 2026 Lehrer-Graiwer Joshua Director grant 64,000 4 on EDGAR
Lehrer-Graiwer Joshua Director 3 on EDGAR
Feb 2, 2026 Sapir Alex See Remarks grant 650,000 4 on EDGAR
Feb 2, 2026 Tourangeau Greg Principal Accounting Officer grant 57,000 4 on EDGAR
Feb 2, 2026 Oltmans Curtis Gale Chief Legal Officer grant 170,000 4 on EDGAR
Feb 2, 2026 Gould Robert J Director sale 15,000 $10.72 $160,857 4 on EDGAR
Feb 2, 2026 Musso Alan A Chief Financial Officer grant 170,000 4 on EDGAR
Jan 2, 2026 Gould Robert J Director sale 15,000 $10.87 $163,089 4 on EDGAR
Jan 2, 2026 Gould Robert J Insider sale 15,000 $11.87 $178,089 4 on EDGAR
Dec 8, 2025 RA CAPITAL MANAGEMENT, L.P. Insider sale 1,377,020 $13.33 $18,355,677 4 on EDGAR
Nov 19, 2025 Gould Robert J Insider sale 15,000 $11.03 $165,495 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query FULC context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access